Insight

Dec 26, 2024, 14:23

Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma

Haematologica shared a post on X:

“Long non-coding RNA (lncRNA) have emerged as key players in the regulation of various biological processes.

A new study explores the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma.”

lncRNA

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Authors: Noemi Puccio, Gloria Manzotti, Elisabetta Mereu, Federica Torricelli, Domenica Ronchetti, Michela Cumerlato, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Valentina Traini, Veronica Manicardi, Valentina Fragliasso, Yvan Torrente, Nicola Amodio, Niccolò Bolli, Elisa Taiana, Alessia Ciarrocchi, Roberto Piva, Antonino Neri

lncRNA

Alessia Ciarrocchi Antonino Neri biological processes cancer Domenica Ronchetti Elisa Taiana Elisabetta Mereu Federica Torricelli Gloria Manzotti Haematologica Ilaria Craparotta Laura Di Rito lncRNA Marco Bolis Michela Cumerlato multiple myeloma Niccolò Bolli Nicola Amodio Noemi Puccio OncoDaily Oncology Roberto Piva Valentina Fragliasso Valentina Traini Veronica Manicardi Yvan Torrente

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth